{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:04:26Z","timestamp":1784329466720,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"DOI":"10.7759\/cureus.112879","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:57:37Z","timestamp":1784329057000},"source":"Crossref","is-referenced-by-count":0,"title":["Performance and Cost-Effectiveness of Tumor Tissue-Modified Viral (TTMV)-Human Papillomavirus (HPV) DNA for Surveillance of HPV-Associated Oropharyngeal Cancer Compared With Standard Positron Emission Tomography (PET)"],"prefix":"10.7759","author":[{"given":"Phoebus","family":"Sun Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karna T","family":"Sura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus-attributable cancers - United States, 2012-2016","volume":"68","author":"Senkomago V","year":"2019","unstructured":"Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human papillomavirus-attributable cancers - United States, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019, 68:724-8. 10.15585\/mmwr.mm6833a3","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner M","year":"2022","unstructured":"Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022, 19:306-27. 10.1038\/s41571-022-00603-7","journal-title":"Nat Rev Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.2530","article-title":"Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017","volume":"5","author":"Liao CI","year":"2022","unstructured":"Liao CI, Francoeur AA, Kapp DS, Caesar MA, Huh WK, Chan JK. Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017. JAMA Netw Open. 2022, 5:e222530. 10.1001\/jamanetworkopen.2022.2530","journal-title":"JAMA Netw Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi AK","year":"2008","unstructured":"Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008, 26:612-9. 10.1200\/JCO.2007.14.1713","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.08.015","article-title":"Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications","volume":"103","author":"Lu DJ","year":"2018","unstructured":"Lu DJ, Luu M, Mita A, et al.. Human papillomavirus-associated oropharyngeal cancer among patients aged 70 and older: Dramatically increased prevalence and clinical implications. Eur J Cancer. 2018, 103:195-204. 10.1016\/j.ejca.2018.08.015","journal-title":"Eur J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e3181f895c1","article-title":"Human papillomavirus detection in head and neck squamous cell carcinomas","volume":"17","author":"Snow AN","year":"2010","unstructured":"Snow AN, Laudadio J. Human papillomavirus detection in head and neck squamous cell carcinomas. Adv Anat Pathol. 2010, 17:394-403. 10.1097\/PAP.0b013e3181f895c1","journal-title":"Adv Anat Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002134","article-title":"Circulating tumor HPV DNA in patients with head and neck carcinoma: correlation with HPV genotyping","volume":"48","author":"Mijares K","year":"2024","unstructured":"Mijares K, Ferrandino R, Chai R, Roof S, Bhardwaj S, Posner M, Westra WH. Circulating tumor HPV DNA in patients with head and neck carcinoma: correlation with HPV genotyping. Am J Surg Pathol. 2024, 48:80-7. 10.1097\/PAS.0000000000002134","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2018.10.013","article-title":"Diagnostic accuracy of F-18 FDG PET or PET\/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; a systematic review and meta-analysis","volume":"40","author":"Kim SJ","year":"2019","unstructured":"Kim SJ, Pak K, Kim K. Diagnostic accuracy of F-18 FDG PET or PET\/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; a systematic review and meta-analysis. Am J Otolaryngol. 2019, 40:297-305. 10.1016\/j.amjoto.2018.10.013","journal-title":"Am J Otolaryngol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0194599815621742","article-title":"Detecting residual\/recurrent head neck squamous cell carcinomas using PET or PET\/CT: systematic review and meta-analysis","volume":"154","author":"Cheung PK","year":"2016","unstructured":"Cheung PK, Chin RY, Eslick GD. Detecting residual\/recurrent head neck squamous cell carcinomas using PET or PET\/CT: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2016, 154:421-32. 10.1177\/0194599815621742","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.055806","article-title":"Does 18F-FDG PET\/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?","volume":"50","author":"Abgral R","year":"2009","unstructured":"Abgral R, Querellou S, Potard G, et al.. Does 18F-FDG PET\/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?. J Nucl Med. 2009, 50:24-9. 10.2967\/jnumed.108.055806","journal-title":"J Nucl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05684-2","article-title":"FDG-PET\/CT in the surveillance of head and neck cancer following radiotherapy","volume":"277","author":"Ris\u00f8r LM","year":"2020","unstructured":"Ris\u00f8r LM, Loft A, Berthelsen AK, et al.. FDG-PET\/CT in the surveillance of head and neck cancer following radiotherapy. Eur Arch Otorhinolaryngol. 2020, 277:539-47. 10.1007\/s00405-019-05684-2","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/cyt.12581","article-title":"Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary","volume":"29","author":"Rollo F","year":"2018","unstructured":"Rollo F, Dona' MG, Pellini R, Pichi B, Marandino F, Covello R, Benevolo M. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary. Cytopathology. 2018, 29:449-54. 10.1111\/cyt.12581","journal-title":"Cytopathology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1758-3284-4-15","article-title":"The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid","volume":"4","author":"Jacobson JJ","year":"2012","unstructured":"Jacobson JJ, Epstein JB, Eichmiller FC, et al.. The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid. Head Neck Oncol. 2012, 4:15. 10.1186\/1758-3284-4-15","journal-title":"Head Neck Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2018.05.006","article-title":"ACR neck Imaging Reporting and Data Systems (NI-RADS): a White Paper of the ACR NI-RADS Committee","volume":"15","author":"Aiken AH","year":"2018","unstructured":"Aiken AH, Rath TJ, Anzai Y, et al.. ACR neck Imaging Reporting and Data Systems (NI-RADS): a White Paper of the ACR NI-RADS Committee. J Am Coll Radiol. 2018, 15:1097-108. 10.1016\/j.jacr.2018.05.006","journal-title":"J Am Coll Radiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.1937","article-title":"Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma","volume":"32","author":"Fakhry C","year":"2014","unstructured":"Fakhry C, Zhang Q, Nguyen-Tan PF, et al.. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014, 32:3365-73. 10.1200\/JCO.2014.55.1937","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/lary.30701","article-title":"Novel HPV associated oropharyngeal squamous cell carcinoma surveillance DNA assay cost analysis","volume":"133","author":"Lin MG","year":"2023","unstructured":"Lin MG, Zhu A, Read PW, Garneau J, McLaughlin C. Novel HPV associated oropharyngeal squamous cell carcinoma surveillance DNA assay cost analysis. Laryngoscope. 2023, 133:3006-12. 10.1002\/lary.30701","journal-title":"Laryngoscope"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.483","article-title":"Cost-effectiveness analysis of PET-CT surveillance after treatment of human papillomavirus-positive oropharyngeal cancer","volume":"170","author":"Lin ME","year":"2024","unstructured":"Lin ME, Castellanos CX, Acevedo JR, Yu JC, Kokot NC. Cost-effectiveness analysis of PET-CT surveillance after treatment of human papillomavirus-positive oropharyngeal cancer. Otolaryngol Head Neck Surg. 2024, 170:122-31. 10.1002\/ohn.483","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-010-1461-2","article-title":"The follow-up of patients with head and neck cancer: an analysis of 1,039 patients","volume":"268","author":"Kothari P","year":"2011","unstructured":"Kothari P, Trinidade A, Hewitt RJ, Singh A, O'Flynn P. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients. Eur Arch Otorhinolaryngol. 2011, 268:1191-200. 10.1007\/s00405-010-1461-2","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound CR","year":"1999","unstructured":"Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999, 281:1591-7. 10.1001\/jama.281.17.1591","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30415-2","article-title":"(18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial","volume":"20","author":"Calais J","year":"2019","unstructured":"Calais J, Ceci F, Eiber M, et al.. (18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019, 20:1286-94. 10.1016\/S1470-2045(19)30415-2","journal-title":"Lancet Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.6060","article-title":"Clinical validity of TTMV-HPV DNA liquid biopsies for the diagnosis and surveillance of HPV-associated oropharyngeal carcinoma","volume":"41","author":"Roof SA","year":"2023","unstructured":"Roof SA, Ferrandino R, Chen S, et al.. Clinical validity of TTMV-HPV DNA liquid biopsies for the diagnosis and surveillance of HPV-associated oropharyngeal carcinoma. J Clin Oncol. 2023, 41:6060. 10.1200\/JCO.2023.41.16_suppl.6060","journal-title":"J Clin Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2023.1937","article-title":"Performance of liquid biopsy for diagnosis and surveillance of human papillomavirus-associated oropharyngeal cancer","volume":"149","author":"Ferrandino RM","year":"2023","unstructured":"Ferrandino RM, Chen S, Kappauf C, et al.. Performance of liquid biopsy for diagnosis and surveillance of human papillomavirus-associated oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2023, 149:971-7. 10.1001\/jamaoto.2023.1937","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1478","article-title":"Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance","volume":"29","author":"Hanna GJ","year":"2023","unstructured":"Hanna GJ, Roof SA, Jabalee J, et al.. Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance. Clin Cancer Res. 2023, 29:4306-13. 10.1158\/1078-0432.CCR-23-1478","journal-title":"Clin Cancer Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera BS","year":"2020","unstructured":"Chera BS, Kumar S, Shen C, et al.. Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer. J Clin Oncol. 2020, 38:1050-8. 10.1200\/JCO.19.02444","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0562","article-title":"Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma","volume":"28","author":"Berger BM","year":"2022","unstructured":"Berger BM, Hanna GJ, Posner MR, et al.. Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma. Clin Cancer Res. 2022, 28:4292-301. 10.1158\/1078-0432.CCR-22-0562","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34823","article-title":"Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols","volume":"129","author":"Haring CT","year":"2023","unstructured":"Haring CT, Kana LA, Dermody SM, et al.. Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols. Cancer. 2023, 129:2817-27. 10.1002\/cncr.34823","journal-title":"Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/436657-performance-and-cost-effectiveness-of-tumor-tissue-modified-viral-ttmv-human-papillomavirus-hpv-dna-for-surveillance-of-hpv-associated-oropharyngeal-cancer-compared-with-standard-positron-emission-tomography-pet","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:57:37Z","timestamp":1784329057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/436657-performance-and-cost-effectiveness-of-tumor-tissue-modified-viral-ttmv-human-papillomavirus-hpv-dna-for-surveillance-of-hpv-associated-oropharyngeal-cancer-compared-with-standard-positron-emission-tomography-pet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.112879","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}